(NASDAQ: INGN) Inogen's forecast annual revenue growth rate of 4.98% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.02%.
Inogen's revenue in 2025 is $339,960,000.On average, 2 Wall Street analysts forecast INGN's revenue for 2025 to be $9,518,486,977, with the lowest INGN revenue forecast at $9,518,083,668, and the highest INGN revenue forecast at $9,518,890,285. On average, 2 Wall Street analysts forecast INGN's revenue for 2026 to be $10,100,326,894, with the lowest INGN revenue forecast at $10,080,295,898, and the highest INGN revenue forecast at $10,120,357,889.
In 2027, INGN is forecast to generate $10,591,422,369 in revenue, with the lowest revenue forecast at $10,591,422,369 and the highest revenue forecast at $10,591,422,369.